Found 167 matching trials
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line PHASE2 In second line with advanced or recurrent biliary tract cancer refractory t...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX PHASE3 The aim of this adaptive Phase 3 trial is to show a statistically significa...
Show More Location
Compassionate Cancer Care Medical Group, Inc
Learn More & Join Trial
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Pancreatic Adenocarcinoma Signature Stratification for Treatment PHASE2 This is a randomized multicentre phase II trial with a large translational ...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer PHASE1 This clinical trial tests how well dynamic contrast enhanced magnetic reson...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) PHASE1 This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer PHASE2 This study is comparing two combinations of chemotherapy treatments in pati...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma N/A Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a...
Show More Location
Zhejiang Province Cancer Hospital
Learn More & Join Trial